-
-
-
-
-
-
-
Vyant Bio Reports Second Quarter and First Half 2022 Results and Provides Strategic and Business Highlights
-
-
-
-
-
-
-
Vyant Bio Reports Fourth Quarter and Year-End 2021 Results and Provides Strategic and Business Highlights
-
-
-
-
-
-
-
Vyant Bio (VYNT) Issues Letter to Shareholders
-
-
-
-
-
-
-
Vyant Bio Reports Third Quarter 2021 Results and Provides Strategic Business Updates
-
-
-
-
-
-
-
Vyant Bio Announces Robert T. Fremeau, Jr. Ph.D. as Chief Scientific Officer
-
-
-
-
-
-
-
Vyant Bio and Cyclica Announce a Strategic Collaboration to Identify Compounds to Treat CDKL5 Deficiency Disorder
-
-
-
-
-
-
-
Vyant Bio to Present at A.G.P.’s Virtual MedTech Summer Conference
-
1,155,234 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

